StonvexLoading…
StonvexCore line items from CATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2022 2022-06-30 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $1.43M | $0.00 | $10.79M | $5.38M |
Operating Income | $-40.94M | $-8.67M | $-6.42M | $-3.91M |
Net Income | $-46.51M | $-10.76M | $-7.27M | $-3.85M |
EPS (Diluted) | $-1.74 | $-0.08 | $-0.05 | $-0.03 |
Total Assets | $97.89M | $58.09M | $64.44M | Not available |
Total Liabilities | $22.71M | $3.45M | $3.16M | Not available |
Cash & Equivalents | $9.24M | $20.99M | $55.89M | $60.35M |
Free Cash Flow OCF − CapEx | $-37.98M | $-10.68M | $-7.98M | $-3.53M |
Shares Outstanding | 28.18M | 142.11M | 142.04M | 141.94M |